Arkolith/Insider Trading/BVS/Form 4

D'Adamio Anthony

SVP & General CounselBioventus Inc. (BVS) · full profile →Form 4 · filed Mar 17, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
10
4 non-derivative · 6 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 13, 2026Tax withholding(F)4K$8.62$33K143K
Mar 13, 2026Option exercise(M)9K—$0147K
Mar 13, 2026Tax withholding(F)4K$8.62$33K148K
Mar 13, 2026Option exercise(M)9K—$0152K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 13, 2026Grant(A)83K—$083K
Mar 13, 2026Option exercise(M)9K—$00
Mar 13, 2026Grant(A)92K—$092K
Mar 13, 2026Option exercise(M)9K—$026K
Mar 14, 2025Grant(A)35K—$035K
Mar 14, 2025Grant(A)40K—$040K

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001835184-26-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML